Anpac Bio LOGO.jpg
AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) for Registration Testing of Its Multi-Cancer CDA Device
23 août 2021 07h30 HE | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Aug. 23, 2021 (GLOBE NEWSWIRE) -- via Investor Wire – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations...
22157.jpg
European Biosimilars Market Report 2021:Biosimilars for Cancers Accounts for > 20% Market
20 août 2021 08h28 HE | Research and Markets
Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Outlook on the Fibroblast Growth Factor Receptor Inhibitor Drug Global Market to 2026 - Focus on Belvesra, Pemazyre and Truseltiq
16 août 2021 04h33 HE | Research and Markets
Dublin, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The "Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity & Clinical Trials Insight 2026" report has been added to...
22157.jpg
Global Clinical Trial Imaging Markets, 2021-2026: Opportunities in Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, and Radiopharmaceuticals
11 août 2021 06h33 HE | Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trial Imaging Market by Software & Services (Operational Imaging, Read Analysis), Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO),...
Apollomics_Logos Final-01.png
Apollomics, Inc. Doses First Patient in a Phase I Clinical Trial of APL-102
10 août 2021 07h10 HE | Apollomics, Inc.
FOSTER CITY, Calif. and HANGZHOU, China and SHANGHAI, China, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of...
22157.jpg
Anaplastic Lymphoma Kinase ALK Inhibitors Market, 2026
10 août 2021 04h48 HE | Research and Markets
Dublin, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Anaplastic Lymphoma Kinase ALK Inhibitors Market, Drug Sales, Price & Clinical Trials Insight 2026" report has been added to...
BRT-logo-final.png
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
09 août 2021 11h58 HE | BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
22157.jpg
Global EZH2 Inhibitor Market Report 2021: Market will Grow with a CAGR of More than 110% to Surpass $1 Billion by 2026
05 août 2021 10h13 HE | Research and Markets
Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Global EZH2 Inhibitor Market Opportunity, Sales & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
05 août 2021 07h30 HE | Wave Life Sciences USA, Inc.
Dosing underway in FOCUS-C9 clinical trial of WVE-004 in C9-ALS / C9-FTD – first oligonucleotide using PN backbone chemistry modifications in clinical study Recruitment ongoing for clinical trials in...
22157.jpg
2021 Hybrid/Virtual/Decentralized Clinical Trials Market Outlook
05 août 2021 04h43 HE | Research and Markets
Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Hybrid/Virtual/Decentralized Clinical Trials Market Outlook" report has been added to ResearchAndMarkets.com's offering. Change is hard and it can...